A. Gerbitz

发表

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

E. Holler, H. Greinix, A. Kiani, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.

A. Ganser, N. Kröger, M. Labopin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.

R. David, M. Hacker, C. Rischpler, 2008, Experimental hematology.

Vitamin D–dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma

A. Mackensen, D. Mougiakakos, R. Jitschin, 2015, Science Translational Medicine.

Targeting high‐grade B cell lymphoma with CD19‐specific T cells

E. Kremmer, W. Uckert, G. Bornkamm, 2014, International journal of cancer.

Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma

J. Lipton, A. Viswabandya, J. Mattsson, 2022, European journal of haematology.

CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.

R. Claus, A. Schmitt-Graeff, R. Negrin, 2010, Cancer research.

Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.

R. David, W. Franz, M. Zaruba, 2011, Cardiovascular research.

Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, J. Klusmann, M. Lübbert, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma

A. Polack, G. Bornkamm, J. Mautner, 1999, Oncogene.

Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy.

L. Bullinger, A. Moosmann, T. Blankenstein, 2022, Cytotherapy.

Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia

J. Crawford, G. Hill, J. Ferrara, 1999 .

Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction

M. Hacker, W. Franz, T. Weinberger, 2011, Journal of cellular and molecular medicine.

By Activating Akt/mtor Signaling Function of Human Double-negative T Cells Il-7 Abrogates the Immunosuppressive

A. Mackensen, F. Ferrazzi, A. Gerbitz, 2022 .

Isolation and transplantation of allogeneic pulmonary endothelium derived from GFP transgenic mice.

E. Holler, R. Andreesen, G. Eissner, 2003, Journal of immunological methods.

Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.

E. Holler, R. Andreesen, G. Hildebrandt, 2007, International journal of molecular medicine.

Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL

A. Mackensen, A. Moosmann, M. Hummel, 2022, PLoS pathogens.

Hyporesponsiveness of Donor Cells to Lipopolysaccharide Stimulation Reduces the Severity of Experimental Idiopathic Pneumonia Syndrome: Potential Role for a Gut-Lung Axis of Inflammation1

J. Crawford, L. Kobzik, G. Hill, 2000, The Journal of Immunology.

Gut-Lung Axis of Inflammation Pneumonia Syndrome : Potential Role for a Severity of Experimental Idiopathic Lipopolysaccharide Stimulation Reduces the Hyporesponsiveness of Donor Cells to Brewer and

J. Crawford, G. Hill, T. Martin, 2000 .

Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis.

E. Holler, R. Andreesen, G. Eissner, 2005, Endothelium : journal of endothelial cell research.

Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.

J. Lipton, A. Viswabandya, J. Mattsson, 2020, Hematology/oncology and stem cell therapy.

Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice

C. Schmitt, C. Loddenkemper, T. Blankenstein, 2012, PloS one.

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

M. Mohty, E. Holler, H. Greinix, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Probiotic effects on experimental graft-versus-host disease: let them eat yogurt.

J. Schölmerich, E. Holler, R. Andreesen, 2004, Blood.

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia

M. Minden, Steven M. Chan, Tong Zhang, 2022, EJHaem.

Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.

A. Elmaagacli, E. Holler, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

D. Mougiakakos, R. Jitschin, P. Ljungman, 2013, Leukemia.

Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.

M. Fiegl, H. Kolb, H. Campe, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma

L. Bullinger, P. Mertins, H. Rahn, 2022, Cancer immunology research.

Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.

S. Kirchner, S. Haffner, E. Holler, 2002, Blood.

Cerebral Endothelial Expression of Adhesion Molecules in Mice with Chronic Graft-Versus-Host Disease

A. Straube, E. Holler, A. Gerbitz, 2004, Stroke.

Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.

P. Hillemanns, E. Holler, G. Eissner, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation

A. Logan, E. Holler, L. Akard, 2020, Antimicrobial Agents and Chemotherapy.

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

M. Rehli, A. Mackensen, D. Mougiakakos, 2015 .

Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation.

E. Holler, R. Andreesen, G. Eissner, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.

G. Hill, J. Ferrara, L. Pan, 2000, Transplantation.

Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults

J. Lipton, A. Viswabandya, S. Alibhai, 2022, Bone Marrow Transplantation.

Identification of MHC II-Restricted Minor Histocompatibility Antigens After HLA-Identical Stem-Cell Transplantation

G. Bornkamm, U. Behrends, J. Mautner, 2010, Transplantation.

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

H. Einsele, J. Johansson, W. Wiktor-Jedrzejczak, 2022, Bone Marrow Transplantation.

High serum concentrations of ciclosporin related to administration of tigecycline

W. Hiddemann, C. Schmidt, A. Gerbitz, 2008, European Journal of Clinical Pharmacology.

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.

J. Crawford, G. Hill, J. Ferrara, 1999, The Journal of clinical investigation.

Targeting c-MYC with T-Cells

G. Bornkamm, T. Kammertoens, H. Bruns, 2013, PloS one.

Humanized c-Myc Mouse

R. Kühn, U. Zimber-Strobl, G. Bornkamm, 2012, PloS one.

Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma

A. Hartmann, L. Distel, C. Daniel, 2014, PloS one.

Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.

L. Bullinger, M. Heuser, F. Thol, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Burkitt Lymphoma in the Mouse

Chen-feng Qi, A. Polack, A. Kovalchuk, 2000, The Journal of experimental medicine.

Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Bone Marrow Transplantation.

Reconstitution of T cell immunity against EBV in the immunocompromised host by adoptive transfer of peptide-stimulated T cells after allogeneic stem cell transplantation

A. Mackensen, A. Moosmann, M. Hummel, 2021, bioRxiv.

Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation

D. Lenze, M. Hummel, V. Seitz, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow T

M. Labopin, P. Chevallier, D. Blaise, 2020, Cancer.

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

J. Crawford, G. Hill, D. Rossignol, 2001, The Journal of clinical investigation.

Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation.

J. Crawford, L. Kobzik, G. Hill, 2000, Transplantation.

Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: interleukin-10 protects against transendothelial migration.

E. Holler, G. Eissner, G. Bornkamm, 1997, Transplantation.

High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission

W. Hiddemann, G. Ledderose, D. Oruzio, 2008, Bone Marrow Transplantation.

A Role for CD54 (Intercellular Adhesion Molecule-1) in Leukocyte Recruitment to the Lung During the Development of Experimental Idiopathic Pneumonia Syndrome

P. Ward, E. Holler, R. Andreesen, 2005, Transplantation.

A Role for Tumor Necrosis Factor-&agr;-Mediated Endothelial Apoptosis in the Development of Experimental Idiopathic Pneumonia Syndrome

E. Holler, G. Eissner, L. Kobzik, 2004, Transplantation.

IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling

A. Ekici, A. Mackensen, F. Ferrazzi, 2015, The Journal of Immunology.

Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.

Comparison of outcomes after second allogeneic hematopoietic cell transplantation versus donor lymphocyte infusion in allogeneic hematopoietic cell transplant patients

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Clinical Lymphoma Myeloma and Leukemia.

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant

J. Lipton, A. Viswabandya, E. Atenafu, 2020, European journal of haematology.

Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Transplantation and cellular therapy.

Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Leukemia & lymphoma.

IMPROVING SAFETY AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE.

J. Lipton, A. Viswabandya, M. Remberger, 2022, Transplantation and cellular therapy.

Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.

J. Lipton, A. Viswabandya, S. Cyriac, 2021, Clinical lymphoma, myeloma & leukemia.

Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation

E. Thiel, M. Neumann, T. Burmeister, 2011, Annals of Hematology.

Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.

E. Holler, H. Greinix, G. Kobbe, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: a Single-Center Study.

J. Lipton, A. Viswabandya, M. Remberger, 2021, Transplantation and cellular therapy.

Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center.

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Hematology/oncology and stem cell therapy.

Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience

J. Lipton, A. Viswabandya, I. Novitzky-Basso, 2023, Annals of Hematology.

Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Bone Marrow Transplantation.

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Deepali Kumar, J. Lipton, A. Viswabandya, 2020, Leukemia & lymphoma.

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts

A. Mackensen, A. Moosmann, M. Aigner, 2018, Journal of Translational Medicine.

Prolactin, a potential biomarker for chronic GVHD activity

S. Ezzat, J. Lipton, A. Viswabandya, 2020, European journal of haematology.

Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

Less is More: Superior GVHD-Free/Relapse-Free Survival with Reduced Intensity Conditioning and Dual T-cell Depletion in AML.

A. Viswabandya, J. Mattsson, F. Michelis, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

A. Ganser, E. Holler, H. Greinix, 2008 .

High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Blood cell therapy.

Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation

A. Straube, E. Holler, K. Bise, 2001, Neurology.

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

M. Minden, Zhaolei Zhang, Steven M. Chan, 2021, Bone Marrow Transplantation.

Risk factors for graft failure in allogeneic hematopoietic stem cell transplantation: a single-center study

A. Viswabandya, M. Remberger, J. Lipton, 2020, Cellular Therapy and Transplantation.

Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.